Viewing Study NCT06046495


Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2025-12-27 @ 9:52 PM
Study NCT ID: NCT06046495
Status: RECRUITING
Last Update Posted: 2025-04-23
First Post: 2023-09-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer
Sponsor: Avistone Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module